Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
CORRECT-MRD II: Second Colorectal Cancer Clinical Validation Study to Predict Recurrence Using a Circulating Tumor DNA Assay to Detect Minimal Residual Disease
SpaceIT Hydrogel System for Perirectal Spacing in Subjects with Low to Intermediate Risk Prostate Cancer Undergoing External Beam Radiotherapy EBRT: A multicenter, randomized, controlled clinical study HYDROSPACE
Study Type: Other
Phase: Device
NCTID: NCT06451614
Principal Investigator:
Xinglei Shen
A Phase I Study of ZEN003694 ZEN3694 in Combination with Cetuximab and Encorafenib in Patients with Refractory BRAF V600E Metastatic Colorectal Cancer
Study Type: Treatment
Phase: I
NCTID: NCT06102902
Principal Investigator:
Haoran Li
Adaptive Intervention to Maximize Colorectal Screening in Safety Net Populations
Study Type: Prevention
Phase: N/A
NCTID: NCT03100461
Principal Investigator:
Keith Allen Greiner JR
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The MM Study
Phase II Trial, NIS793E12201, An Open-Label, Three-Arm Phase II Study Of NIS793 With Or Without Spartalizumab In Combination With Standard Of Care Anti-Cancer Therapy For The Second Line Treatment Of Metastatic Colorectal Cancer
MOUNTAINEER: A Phase II, Open Label Study of Tucatinib Combined with Trastuzumab in Patients with HER2+ Metastatic Colorectal Cancer
A Phase II, Randomized, Open-label Study of Onvansertib in Combination with FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-line Treatment of Metastatic Colorectal Cancer in Patients with a KRAS or NRAS Mutation
Study Type: Treatment
Phase: II
NCTID: NCT06106308
Principal Investigator:
Anup Kasi